ACOG: Rega marang bathi mangsa ngarep Alpha Cognition Inc.
Drug development for brain pathologies at Alpha Cognition (ACOG) relies on patent protection and strict regulatory oversight, which curbs the expansion of generic alternatives. This price chart confirms a current P/E multiple of 0.00. The business is currently transitioning to the commercialization of its primary Alzheimer's disease treatment, although high dependence on a single product creates significant market risks during the sales rollout.
Rincian metrik keuangan lan pasar Alpha Cognition Corp (ACOG)
- nilai saham lan prakiraan konsensus rega:
- informasi kapitalisasi pasar:
- data ekuitas miturut neraca:
- indikator total utang lan likuiditas perusahaan:
Rasio Total Utang marang Ekuitas Alpha Cognition|ACOG - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal Alpha Cognition|ACOG - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Alpha Cognition Inc|ACOG - Utang jangka dawa|Utang jangka cendhak perusahaan Alpha Cognition|Likuiditas cepet alphacognition.com
- statistik bathi lan rasio pasar:
ACOG - Bathi perusahaan|Proyeksi bathi mangsa ngarep Alpha Cognition|ACOG - Periode bali modal bisnis|Prakiraan rega marang bathi Alpha Cognition|ACOG - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA Alpha Cognition Inc|ACOG - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Alpha Cognition|ACOG - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan alphacognition.com|ACOG - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Alpha Cognition
Analisis fundamental perusahaan:ACOG Alpha Cognition Inc.
Alpha Cognition is developing innovative treatments for Alzheimer's disease for the global neurology market. The forward P/E is calculated as the ratio of the current share price to the projected earnings for the future period. This multiple measures market expectations regarding business scaling rates and the efficacy of new drugs. A high premium confirms investor confidence in growth but increases the risk of a correction. By analyzing the forward P/E valuation dynamics of Alpha Cognition, the strategist determines the sustainability of its capitalization.
Pesaing Alpha Cognition (ACOG)
Rega marang bathi mangsa ngarep Biogen (BIIB)|Rega marang bathi mangsa ngarep NBIX (Neurocrine)|Rega marang bathi mangsa ngarep Regencell RGC|AXSM (Axsome Corp) - Rasio rega marang bathi sing dikarepake|ACADIA Pharmaceuticals - Pangali Forward P/E|Pangali mangsa ngarep rega marang bathi XENE (xenon-pharma.com)|VKTX: Pangali Forward P/E|Supernus Pharmaceuticals, Inc. (SUPN) - Pangali Forward P/E|Prakiraan rega marang bathi CPRX|DNLI: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E HRMY|Prakiraan rega marang bathi biohavenpharma.com BHVN|Rega marang bathi mangsa ngarep Amylyx Pharmaceuticals, Inc. AMLX|Trevi Therapeutics Inc (TRVI) - Rasio prakiraan rega marang bathi|Praxis Medicines - Pangali Forward P/E|Pangali forward rega marang bathi Anavex Life Sciences Corp (AVXL)|CeriBell, Inc. (CBLL) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep PRTA|ALEC (Alector Inc.) - Pangali Forward P/E|Annexon Biosciences (ANNX) - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi OMER (Omeros Corporation)|Rasio kapitalisasi marang bathi mangsa ngarep NGNE|Pangali Forward P/E ACIU (AC Immune)|Kapitalisasi marang proyeksi bathi voyagertherapeutics.com (VYGR)|NMRA - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi Scilex Holding|Tevogen Bio Holdings, Inc. (TVGN) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep CGTX|IKT (Inhibikase Therapeutics) - Pangali Forward P/E|Pangali Forward P/E cassavasciences.com|Pangali Forward P/E ASRT|Prakiraan rega marang bathi coyatherapeutics.com COYA|Rega marang bathi mangsa ngarep Vistagen VTGN|Ovid Therapeutics Inc (OVID) - Rasio prakiraan rega marang bathi|Acumen Pharmaceuticals - Pangali Forward P/E|Pangali forward rega marang bathi cervomed.com (CRVO)|alteritytherapeutics.com (ATHE) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep CLNN|PEPG (PepGen Inc) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Jupiter Neurosciences, Inc. JUNS|Prakiraan rega marang bathi RLMD (Relmada Therapeutics)|Pangali Forward P/E annovisbio.com (ANVS)|Rega marang bathi mangsa ngarep Grace Therapeutics GRCE|Pangali mangsa ngarep rega marang bathi AIFF|KLTO - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi NeuroSense Therapeutics|RVPH: Pangali Forward P/E|MetaVia (MTVA) - Pangali Forward P/E|Rega marang bathi mangsa ngarep NeurAxis|Rega marang bathi mangsa ngarep HSDT|Rega marang bathi mangsa ngarep Passage Bio, Inc. (PASG)|NEUP: Rasio rega marang bathi sing dikarepake|Pangali Forward P/E NERV (Minerva Neurosciences)|Pangali mangsa ngarep rega marang bathi ATHA|Addex Therapeutics Ltd - Pangali Forward P/E|ALZN - Pangali Forward P/E|CYCN (cyclerion.com) - Prakiraan rega marang bathi|Protagenic Therapeutics, Inc. - Pangali mangsa ngarep rega marang bathi|KTTA (Pasithea Therapeutics Corp) - Pangali Forward P/E|Prakiraan rega marang bathi Cortigent Medical (CRGT)|Rega marang bathi mangsa ngarep Avenue Therapeutics, Inc. (ATXI)|BCLI - Rasio prakiraan rega marang bathi|Pangali Forward P/E CARA (Cara Therapeutics, Inc)|Pangali forward rega marang bathi Chromocell|ELYM - Rega marang bathi mangsa ngarep|ITCI (Intra-Cellular Therapies) - Rasio rega marang bathi mangsa ngarep|LBPH: Pangali Forward P/E|MRNS - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi NKGN|NRBO (NeuroBo Pharma) - Rasio kapitalisasi marang bathi mangsa ngarep|Pangali Forward P/E SAGE|Kapitalisasi marang proyeksi bathi synaptogen.com|Rega marang bathi mangsa ngarep Trevena TRVN|Vigil Neuroscience Inc. (VIGL) - Rasio prakiraan rega marang bathi|WENA - Rega marang bathi mangsa ngarep|CERE (Cerevel Corp) - Rasio rega marang bathi mangsa ngarep
